Abstract

Functional characterization of disease-causing variants at risk loci has been a significant challenge. Here we report a high-throughput single-nucleotide polymorphisms sequencing (SNPs-seq) technology to simultaneously screen hundreds to thousands of SNPs for their allele-dependent protein-binding differences. This technology takes advantage of higher retention rate of protein-bound DNA oligos in protein purification column to quantitatively sequence these SNP-containing oligos. We apply this technology to test prostate cancer-risk loci and observe differential allelic protein binding in a significant number of selected SNPs. We also test a unique application of self-transcribing active regulatory region sequencing (STARR-seq) in characterizing allele-dependent transcriptional regulation and provide detailed functional analysis at two risk loci (RGS17 and ASCL2). Together, we introduce a powerful high-throughput pipeline for large-scale screening of functional SNPs at disease risk loci.

Details

Title
High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing
Author
Zhang, Peng 1 ; Ji-Han, Xia 2 ; Zhu, Jing 3 ; Gao, Ping 2 ; Yi-Jun, Tian 3 ; Du, Meijun 3 ; Yong-Chen, Guo 3 ; Suleman, Sufyan 2 ; Zhang, Qin 2 ; Kohli, Manish 4 ; Tillmans, Lori S 5 ; Thibodeau, Stephen N 5 ; French, Amy J 5 ; Cerhan, James R 6 ; Li-Dong, Wang 7 ; Gong-Hong, Wei 2   VIAFID ORCID Logo  ; Wang, Liang 3   VIAFID ORCID Logo 

 Henan Key Laboratory for Esophageal Cancer Research, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Department of Pathology, MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA 
 Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland 
 Department of Pathology, MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA 
 Department of Oncology, Mayo Clinic, Rochester, MN, USA 
 Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA 
 Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA 
 Henan Key Laboratory for Esophageal Cancer Research, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China 
Pages
1-12
Publication year
2018
Publication date
May 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2042728700
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.